| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |